Insmed Inc (NAS:INSM)
$ 69.61 -1.06 (-1.5%) Market Cap: 12.45 Bil Enterprise Value: 12.18 Bil PE Ratio: 0 PB Ratio: 25.75 GF Score: 67/100

Q4 2023 Insmed Inc Earnings Call Transcript

Feb 22, 2024 / 01:30PM GMT
Release Date Price: $27.15 (-3.86%)
Sara Bonstein
Insmed Incorporated - CFO

Good day and welcome to the Innospec, Inc., fourth-quarter and full year 2023 financial results conference call. (Operator Instructions) I would like to advise all participants this call is being recorded. Thank you. I'd now like to welcome Brian Dunn, Head of Investor Relations to begin the conference. Brian, over to you.

Bryan Dunn
Insmed Incorporated - Head of IR

Thank you, Gavin. Good day, everyone, and welcome to today's conference call to discuss Insmed's Fourth Quarter 2023 financial results and provide a business update. I am joined today by Will Lewis Chair and Chief Executive Officer, and Sarah bonds day and Chief Financial Officer, who will each provide prepared remarks before we open it up for your questions. Before we start, please note that today's call will include forward looking statements based on our current expectations. These statements represent our judgment as of today and inherently involve risks and uncertainties that may cause actual results to differ materially from the results discussed.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot